India · Delayed Price · Currency is INR Hester Biosciences Statistics
Total Valuation
NSE:HESTERBIO has a market cap or net worth of INR 19.11 billion. The enterprise value is 21.07 billion.
| Market Cap | 19.11B |
| Enterprise Value | 21.07B |
Important Dates
The next estimated earnings date is Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Jul 14, 2026 |
Share Statistics
| Current Share Class | 8.51M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.28% |
| Shares Change (QoQ) | +3.80% |
| Owned by Insiders (%) | 63.80% |
| Owned by Institutions (%) | 0.25% |
| Float | 2.66M |
Valuation Ratios
The trailing PE ratio is 14.03.
| PE Ratio | 14.03 |
| Forward PE | n/a |
| PS Ratio | 5.84 |
| PB Ratio | 5.20 |
| P/TBV Ratio | 5.45 |
| P/FCF Ratio | 41.26 |
| P/OCF Ratio | 29.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.68, with an EV/FCF ratio of 45.49.
| EV / Earnings | 15.47 |
| EV / Sales | 6.44 |
| EV / EBITDA | 22.68 |
| EV / EBIT | 28.56 |
| EV / FCF | 45.49 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 2.28 |
| Debt / FCF | 4.21 |
| Interest Coverage | 7.64 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.39% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.25% |
| Revenue Per Employee | 6.78M |
| Profits Per Employee | 2.82M |
| Employee Count | 483 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:HESTERBIO has paid 204.11 million in taxes.
| Income Tax | 204.11M |
| Effective Tax Rate | 12.97% |
Stock Price Statistics
The stock price has increased by +12.80% in the last 52 weeks. The beta is 0.41, so NSE:HESTERBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +12.80% |
| 50-Day Moving Average | 2,366.53 |
| 200-Day Moving Average | 1,849.74 |
| Relative Strength Index (RSI) | 45.60 |
| Average Volume (20 Days) | 8,471 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HESTERBIO had revenue of INR 3.27 billion and earned 1.36 billion in profits. Earnings per share was 158.03.
| Revenue | 3.27B |
| Gross Profit | 2.45B |
| Operating Income | 664.00M |
| Pretax Income | 1.57B |
| Net Income | 1.36B |
| EBITDA | 792.08M |
| EBIT | 664.00M |
| Earnings Per Share (EPS) | 158.03 |
Balance Sheet
The company has 65.38 million in cash and 1.95 billion in debt, with a net cash position of -1.88 billion.
| Cash & Cash Equivalents | 65.38M |
| Total Debt | 1.95B |
| Net Cash | -1.88B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.68B |
| Book Value Per Share | 423.46 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 641.41 million and capital expenditures -178.28 million, giving a free cash flow of 463.13 million.
| Operating Cash Flow | 641.41M |
| Capital Expenditures | -178.28M |
| Depreciation & Amortization | 128.08M |
| Net Borrowing | -361.27M |
| Free Cash Flow | 463.13M |
| FCF Per Share | n/a |
Margins
Gross margin is 74.86%, with operating and profit margins of 20.29% and 41.61%.
| Gross Margin | 74.86% |
| Operating Margin | 20.29% |
| Pretax Margin | 48.08% |
| Profit Margin | 41.61% |
| EBITDA Margin | 24.20% |
| EBIT Margin | 20.29% |
| FCF Margin | 13.86% |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 0.50%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 0.50% |
| Dividend Growth (YoY) | 57.14% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.28% |
| Shareholder Yield | 1.77% |
| Earnings Yield | 7.13% |
| FCF Yield | 2.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |